Department of Musculoskeletal Oncology, Rizzoli Orthopaedic Institute, 3° Clinica Universitaria, Via Pupilli 1, 40136, Bologna, Italy. E-mail address for L. Campanacci:
Clínica Universitária de Ortopedia, Unidade de Tumores do Aparelho Locomotor, Centro Hospitalar e Universitário de Coimbra, Praceta Mota Pinto, 3000 Coimbra, Portugal. E-mail address:
J Bone Joint Surg Am. 2015 Feb 4;97(3):241-50. doi: 10.2106/JBJS.N.00447.
Reconstruction of the proximal part of the tibia in children with megaprostheses or standard composite devices removes the distal femoral physis, and osteoarticular allografts have a high incidence of mechanical failure. We evaluated the results of an alternative original technique for proximal tibial reconstruction after tumor resection.
Nineteen children, ranging in age from six to sixteen years, who underwent surgical resection and reconstruction with a resurfaced allograft-prosthetic composite were retrospectively reviewed at a mean follow-up time of seventy-eight months. Eighteen children had high-grade sarcoma (fourteen had osteosarcoma and four had Ewing sarcoma), and one child had an aggressive giant cell tumor of the proximal part of the tibia. Surgical resection and its complications, disease-free survival of the patients, implant survival, and functional results according to the Musculoskeletal Tumor Society scoring system were analyzed at the time of the latest follow-up.
In all patients, wide surgical margins were obtained and no local recurrence was observed. At the time of the latest follow-up, nine of the eighteen patients with a high-grade malignant tumor were continually disease-free, another six had had metastases but had no evidence of disease, and three had died of the disease. The patient with a giant cell tumor was continually disease-free after 168 months. The mean implant survival was sixty-eight months (range, six to 188 months). The major complications were one deep infection; two nonunions, which healed after surgical revision; and six allograft fractures. Limb-length discrepancy was the most frequent complication but, following contralateral epiphysiodesis, resulted in a mean discrepancy of 1.9 cm at the time of the latest follow-up. At the time of the latest follow-up, eight patients had a Musculoskeletal Tumor Society score deemed as excellent or good.
In children and young teenagers with bone tumors of the proximal part of the tibia requiring an intra-articular resection, knee reconstruction with a resurfaced allograft-prosthetic composite may represent a valid alternative to conventional megaprostheses or to osteoarticular allograft.
在儿童中,使用大型假体或标准复合装置重建胫骨近端会去除股骨远端骨骺,而关节同种异体移植物的机械失效发生率很高。我们评估了一种替代的原始技术用于肿瘤切除后胫骨近端重建的结果。
19 名年龄在 6 至 16 岁之间的儿童,接受了表面置换同种异体-假体复合重建手术,回顾性分析了平均 78 个月的随访结果。18 名儿童患有高级别肉瘤(14 名骨肉瘤,4 名尤文肉瘤),1 名儿童患有胫骨近端侵袭性巨细胞瘤。在最近的随访时,分析了手术切除及其并发症、患者无病生存率、植入物存活率和根据肌肉骨骼肿瘤协会评分系统的功能结果。
在所有患者中,均获得了广泛的手术切缘,未观察到局部复发。在最近的随访时,18 名高级别恶性肿瘤患者中,9 名患者持续无病,另外 6 名患者发生转移但无疾病证据,3 名患者死于疾病。168 个月后,巨细胞瘤患者持续无病。植入物的平均存活率为 68 个月(6-188 个月)。主要并发症为 1 例深部感染;2 例非愈合,经手术修正后愈合;6 例同种异体骨骨折。肢体长度差异是最常见的并发症,但在对侧骺板融合术后,在最近的随访时平均差异为 1.9 厘米。在最近的随访时,8 名患者的肌肉骨骼肿瘤协会评分被认为是优秀或良好。
在需要关节内切除的胫骨近端儿童和青少年骨肿瘤患者中,表面置换同种异体-假体复合重建膝关节可能是传统大型假体或关节同种异体移植物的有效替代方法。